{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T16:42:18Z","timestamp":1777999338579,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2020020201010018"],"award-info":[{"award-number":["2020020201010018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600722"],"award-info":[{"award-number":["81600722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81800872"],"award-info":[{"award-number":["81800872"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.exer.2020.108180","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T20:42:23Z","timestamp":1596832943000},"page":"108180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis"],"prefix":"10.1016","volume":"199","author":[{"given":"Meijuan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianmin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinqin","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.108180_bib1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-720-4_22","article-title":"Rodent models of experimental autoimmune uveitis","volume":"900","author":"Agarwal","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.exer.2020.108180_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exer.2018.07.020","article-title":"A cell penetrating peptide from SOCS-1 prevents ocular damage in experimental autoimmune uveitis","volume":"177","author":"Ahmed","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108180_bib3","article-title":"Anti-inflammatory effect of dehydroxymethylepoxyquinomicin, a nuclear factor-kappaB inhibitor, on endotoxin-induced uveitis in rats in vivo and in vitro","author":"Ando","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.exer.2020.108180_bib4","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/0301-4738.156914","article-title":"Experimental autoimmune uveitis and other animal models of uveitis: an update","volume":"63","author":"Bansal","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib5","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.exer.2020.108180_bib6","first-page":"1891","article-title":"Pharmacotherapy for uveitis: current management and emerging therapy","volume":"8","author":"Barry","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41580-019-0129-z","article-title":"PI3K isoforms in cell signalling and vesicle trafficking","volume":"20","author":"Bilanges","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.exer.2020.108180_bib8","doi-asserted-by":"crossref","unstructured":"Bing, S. J., Shemesh, I., Chong, W. P., Horai, R., Jittayasothorn, Y., Silver, P. B., Sredni, B., and Caspi, R. R.: AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells, J. Autoimmun., doi: 10.1016\/j.jaut.2019.02.006,2019.2019.","DOI":"10.1016\/j.jaut.2019.02.006"},{"key":"10.1016\/j.exer.2020.108180_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12026-008-8031-3","article-title":"Autoimmunity in the immune privileged eye: pathogenic and regulatory T cells","volume":"42","author":"Caspi","year":"2008","journal-title":"Immunol. Res."},{"key":"10.1016\/j.exer.2020.108180_bib10","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1172\/JCI42440","article-title":"A look at autoimmunity and inflammation in the eye","volume":"120","author":"Caspi","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.exer.2020.108180_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000119871","article-title":"Mouse models of experimental autoimmune uveitis","volume":"40","author":"Caspi","year":"2008","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.exer.2020.108180_bib12","first-page":"619","article-title":"Expression of toll-like receptor 4 in uvea-resident tissue macrophages during endotoxin-induced uveitis","volume":"15","author":"Chen","year":"2009","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2020.108180_bib13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09286586.2018.1513042","article-title":"Oral corticosteroid exposure and increased risk of related complications in patients with noninfectious intermediate, posterior, or panuveitis: real-world data analysis","volume":"26","author":"Chirikov","year":"2019","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.exer.2020.108180_bib14","first-page":"473","article-title":"Multimodal analysis of ocular inflammation using the endotoxin-induced uveitis mouse model","volume":"9","author":"Chu","year":"2016","journal-title":"Disease models & mechanisms"},{"key":"10.1016\/j.exer.2020.108180_bib15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/annrheumdis-2018-213131","article-title":"Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative","volume":"77","author":"Constantin","year":"2018","journal-title":"Annals of the rheumatic diseases"},{"key":"10.1016\/j.exer.2020.108180_bib16","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ophtha.2015.10.028","article-title":"Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis","volume":"123","author":"Dick","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108180_bib17","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/bjo.2003.037226","article-title":"Degree, duration, and causes of visual loss in uveitis","volume":"88","author":"Durrani","year":"2004","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","article-title":"The PI3K pathway in human disease","volume":"170","author":"Fruman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.exer.2020.108180_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","article-title":"Alternative activation of macrophages","volume":"3","author":"Gordon","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.exer.2020.108180_bib20","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/ceo.13517","article-title":"Epidemiology of uveitis in urban Australia","volume":"47","author":"Hart","year":"2019","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib21","article-title":"SOCS1 mimetic peptide suppresses chronic intraocular inflammatory disease (uveitis)","volume":"2939370","author":"He","year":"2016","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exer.2020.108180_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jaut.2015.05.011","article-title":"Topical administration of a suppressor of cytokine signaling-1 (SOCS1) mimetic peptide inhibits ocular inflammation and mitigates ocular pathology during mouse uveitis","volume":"62","author":"He","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.exer.2020.108180_bib23","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.3390\/ijms20153615","article-title":"SOCS1-Derived peptide administered by eye drops prevents retinal neuroinflammation and vascular leakage in experimental diabetes","volume":"20","author":"Hern\u00e1ndez","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2020.108180_bib24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1089\/jir.2011.0042","article-title":"Cytokines in autoimmune uveitis","volume":"31","author":"Horai","year":"2011","journal-title":"J. Interferon Cytokine Res. : the official journal of the International Society for Interferon and Cytokine Research"},{"key":"10.1016\/j.exer.2020.108180_bib25","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1158\/1535-7163.MCT-08-0499","article-title":"A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy","volume":"7","author":"Hu","year":"2008","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.exer.2020.108180_bib26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.3389\/fimmu.2018.01713","article-title":"Aryl hydrocarbon receptor regulates apoptosis and inflammation in a murine model of experimental autoimmune uveitis","volume":"9","author":"Huang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2020.108180_bib27","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.exer.2020.108180_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2020.108180_bib29","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.survophthal.2016.12.008","article-title":"Viral posterior uveitis","volume":"62","author":"Lee","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib30","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.3899\/jrheum.121180","article-title":"Response of pediatric uveitis to tumor necrosis factor-alpha inhibitors","volume":"40","author":"Lerman","year":"2013","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.exer.2020.108180_bib31","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/0963689718796196","article-title":"Subretinal transplantation of human amniotic epithelial cells in the treatment of autoimmune uveitis in rats","volume":"27","author":"Li","year":"2018","journal-title":"Cell Transplant."},{"key":"10.1016\/j.exer.2020.108180_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0014-4835(05)80056-9","article-title":"Endotoxin induced uveitis in the mouse: susceptibility and genetic control","volume":"61","author":"Li","year":"1995","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108180_bib33","first-page":"748218","article-title":"Expression of TLR4-MyD88 and NF-kappaB in the iris during endotoxin-induced uveitis","author":"Li","year":"2010","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.exer.2020.108180_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fgene.2018.00425","article-title":"Use of laplacian heat diffusion algorithm to infer novel genes with functions related to uveitis","volume":"9","author":"Lu","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.exer.2020.108180_bib35","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11596-013-1163-2","article-title":"Effects of the 24 N-terminal amino acids of p55PIK on endotoxinstimulated release of inflammatory cytokines by HaCaT cells","volume":"33","author":"Lv","year":"2013","journal-title":"J. Huazhong Univ. Sci. Technol."},{"key":"10.1016\/j.exer.2020.108180_bib36","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.3892\/mmr.2015.3184","article-title":"Mechanisms by which the N-terminal 24 amino acids of the p55 regulatory subunit of phosphatidylinositol 3-kinase affect endotoxin-induced cytokine release in human keratinocytes","volume":"11","author":"Lv","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.exer.2020.108180_bib37","first-page":"67","article-title":"Update on the use of systemic biologic agents in the treatment of noninfectious uveitis","volume":"8","author":"Pasadhika","year":"2014","journal-title":"Biol. Targets & Ther."},{"key":"10.1016\/j.exer.2020.108180_bib38","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1128\/MCB.15.8.4453","article-title":"The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase","volume":"15","author":"Pons","year":"1995","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2020.108180_bib39","doi-asserted-by":"crossref","first-page":"31912","DOI":"10.1038\/srep31912","article-title":"AAV8-Mediated angiotensin-converting enzyme 2 gene delivery prevents experimental autoimmune uveitis by regulating MAPK, NF-kappaB and STAT3 pathways","volume":"6","author":"Qiu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2020.108180_bib40","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4155\/fmc.12.56","article-title":"Targeting the PI3K pathway for cancer therapy","volume":"4","author":"Sadeghi","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.exer.2020.108180_bib41","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1111\/bph.12873","article-title":"Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation","volume":"171","author":"Sande","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2020.108180_bib42","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1292\/jvms.16-0166","article-title":"Tyrosol ameliorates lipopolysaccharide-induced ocular inflammation in rats via inhibition of nuclear factor (NF)-kappaB activation","volume":"78","author":"Sato","year":"2016","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.exer.2020.108180_bib43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4103\/ijo.IJO_35_18","article-title":"Intravitreal therapeutic agents in noninfectious uveitic macular edema","volume":"66","author":"Shah","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib44","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12886-018-0871-6","article-title":"Epidemiology of uveitis (2013-2015) and changes in the patterns of uveitis (2004-2015) in the central Tokyo area: a retrospective study","volume":"18","author":"Shirahama","year":"2018","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib45","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1038\/cti.2016.2","article-title":"Involvement of B cells in non-infectious uveitis","volume":"5","author":"Smith","year":"2016","journal-title":"Clinical & translational immunology"},{"key":"10.1016\/j.exer.2020.108180_bib46","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2015.05.017","article-title":"PI3K inhibitors in inflammation, autoimmunity and cancer","volume":"23","author":"Stark","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.exer.2020.108180_bib47","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cyto.2014.12.017","article-title":"The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU)","volume":"74","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.exer.2020.108180_bib48","first-page":"375","article-title":"Lipocalin 2 suppresses ocular inflammation by inhibiting the activation of NF-kappabeta pathway in endotoxin-induced uveitis, cellular physiology and biochemistry","volume":"46","author":"Tang","year":"2018","journal-title":"international journal of experimental cellular physiology, biochemistry, and pharmacology"},{"key":"10.1016\/j.exer.2020.108180_bib49","article-title":"AAV2-mediated combined subretinal delivery of IFN-alpha and IL-4 reduces the severity of experimental autoimmune uveoretinitis","volume":"7","author":"Tian","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.108180_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019542","article-title":"AAV2-mediated subretinal gene transfer of hIFN-alpha attenuates experimental autoimmune uveoretinitis in mice","volume":"6","author":"Tian","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2020.108180_bib51","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1167\/iovs.17-22679","article-title":"The anti-inflammatory effect of ripasudil (K-115), a rho kinase (ROCK) inhibitor, on endotoxin-induced uveitis in rats","volume":"58","author":"Uchida","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.108180_bib52","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1038\/cdd.2012.70","article-title":"Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells","volume":"19","author":"Wang","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.exer.2020.108180_bib53","doi-asserted-by":"crossref","first-page":"36140","DOI":"10.1038\/srep36140","article-title":"S100A8 promotes migration and infiltration of inflammatory cells in acute anterior uveitis","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2020.108180_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12886-017-0648-3","article-title":"Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series","volume":"17","author":"Winterhalter","year":"2017","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2020.108180_bib55","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/MCB.23.5.1717-1725.2003","article-title":"The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest","volume":"23","author":"Xia","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.exer.2020.108180_bib56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2008.06.012","article-title":"A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images","volume":"87","author":"Xu","year":"2008","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2020.108180_bib57","first-page":"1689","article-title":"The expression of cytokines in the aqueous humor and serum during endotoxin-induced uveitis in C3H\/HeN mice","volume":"16","author":"Xu","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2020.108180_bib58","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/092986711794927694","article-title":"Emerging role of antioxidants in the protection of uveitis complications","volume":"18","author":"Yadav","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.exer.2020.108180_bib59","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.3390\/ijms13067508","article-title":"The effect of toll-like receptor 4 on macrophage cytokines during endotoxin induced uveitis","volume":"13","author":"Yang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2020.108180_bib60","first-page":"2017","article-title":"Low dose of lipopolysaccharide pretreatment preventing subsequent endotoxin-induced uveitis is associated with PI3K\/AKT pathway","volume":"1273940","author":"Zhang","year":"2017","journal-title":"Journal of immunology research"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520304383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483520304383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:29:34Z","timestamp":1762147774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483520304383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":60,"alternative-id":["S0014483520304383"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.108180","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cell-permeable peptide inhibitor of p55PIK signaling alleviates ocular inflammation in mouse models of uveitis","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.108180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108180"}}